Coverart for item
The Resource Cancer immunotherapy : immune suppression and tumor growth, edited by George Prendergast, Elizabeth M. Jaffee

Cancer immunotherapy : immune suppression and tumor growth, edited by George Prendergast, Elizabeth M. Jaffee

Label
Cancer immunotherapy : immune suppression and tumor growth
Title
Cancer immunotherapy
Title remainder
immune suppression and tumor growth
Statement of responsibility
edited by George Prendergast, Elizabeth M. Jaffee
Creator
Contributor
Editor
Subject
Language
eng
Summary
"This book highlights new principles of immune suppression that drive cancer, and offers radically new ideas about how therapy can be improved by attacking these principles. It provides an overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease"--Publisher's description
Cataloging source
N$T
http://bibfra.me/vocab/lite/collectionName
Cancer immunotherapy (Prendergast)
Dewey number
616.994061
Illustrations
illustrations
Index
index present
LC call number
RC271.I45
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QZ 266
http://library.link/vocab/relatedWorkOrContributorName
  • Prendergast, George C.
  • Jaffee, Elizabeth M.
http://library.link/vocab/subjectName
  • Cancer
  • Antineoplastic agents
  • Tumors
  • Neoplasms
  • Antineoplastic Agents
  • Immunotherapy
  • Cancer
  • Antineoplastic agents
  • Tumors
  • HEALTH & FITNESS
  • MEDICAL
Label
Cancer immunotherapy : immune suppression and tumor growth, edited by George Prendergast, Elizabeth M. Jaffee
Instantiates
Publication
Copyright
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier.
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent.
Contents
Section 1: Principles of basic immunology. Components of the immune system -- Adaptive immunity: B cells and antibodies -- Adaptive immunity: T cells and cytokines -- Dendritic cells: antigen processing and presentation -- Mucosal immunity -- Section 2: Principles of cancer immunobiology. Cancer immunoediting: from surveillance to escape -- Immunosurveillance: innate and adaptive antitumor immunity -- Immunological sculpting: natural killer-cell receptors and ligands -- Th17 cells in cancer -- Immune escape: immunosuppressive networks -- Section 3: Introduction to cancer therapeutics. Principles of cytotoxic chemotherapy -- Pharmacokinetics and safety assessment -- Monoclonal antibodies for cancer therapy and prevention: paradigm studies in targeting the neu/ERBB2/HER2 oncoprotein -- Genetic vaccines against cancer: design, testing and clinical performance -- Comprehensive immunomonitoring to guide the development of immunotherapeutic products for cancer -- Section 4: Strategies of passive and active immunotherapy. Adoptive T-cell therapy: engineering T-cell receptors -- Dendritic cell vaccines: sipuleucel-T and other approaches -- Antibodies to stimulate host immunity: lessons from ipilimumab -- Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned -- Adjuvant strategies for vaccines: the use of adjuvants within the cancer vaccine setting -- Section 5: Improving immunotherapeutic responses. Epigenetic approaches: emerging role of histone deacetylase inhibitors in cancer immunotherapy -- Molecular profiling of immunotherapeutic resistance -- Immune stimulatory features of classical chemotherapy -- Immunotherapy and cancer therapeutics: a rich partnership -- Section 6: Targeting strategies to defeat immune suppression. JAK/STAT signaling in myeloid cells: targets for cancer immunotherapy -- Tumor-associated macrophages in cancer growth and progression -- Tumor-induced myeloid-derived suppressor cells -- HyperAcute vaccines: a novel cancer immunotherapy -- Tumor exosomes and their impact on immunity and cancer progression -- Galectins: key players in the tumor microenvironment -- IDO in immune escape: regulation and therapeutic inhibition -- IDO pathway: effect on Foxp3+ Tregs and cancer -- Arginase, nitric oxide synthase, and novel inhibitors of l-arginine metabolism in immune modulation
Control code
847527218
Edition
Second edition.
Extent
1 online resource (xxii, 655 pages)
Form of item
online
Isbn
9780123946331
Media category
computer
Media MARC source
rdamedia.
Media type code
  • c
Other physical details
illustrations (some color)
http://library.link/vocab/ext/overdrive/overdriveId
b4371df8-3eb4-441b-87f6-f641cd6a28c5
Specific material designation
remote
System control number
(OCoLC)847527218
Label
Cancer immunotherapy : immune suppression and tumor growth, edited by George Prendergast, Elizabeth M. Jaffee
Publication
Copyright
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier.
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent.
Contents
Section 1: Principles of basic immunology. Components of the immune system -- Adaptive immunity: B cells and antibodies -- Adaptive immunity: T cells and cytokines -- Dendritic cells: antigen processing and presentation -- Mucosal immunity -- Section 2: Principles of cancer immunobiology. Cancer immunoediting: from surveillance to escape -- Immunosurveillance: innate and adaptive antitumor immunity -- Immunological sculpting: natural killer-cell receptors and ligands -- Th17 cells in cancer -- Immune escape: immunosuppressive networks -- Section 3: Introduction to cancer therapeutics. Principles of cytotoxic chemotherapy -- Pharmacokinetics and safety assessment -- Monoclonal antibodies for cancer therapy and prevention: paradigm studies in targeting the neu/ERBB2/HER2 oncoprotein -- Genetic vaccines against cancer: design, testing and clinical performance -- Comprehensive immunomonitoring to guide the development of immunotherapeutic products for cancer -- Section 4: Strategies of passive and active immunotherapy. Adoptive T-cell therapy: engineering T-cell receptors -- Dendritic cell vaccines: sipuleucel-T and other approaches -- Antibodies to stimulate host immunity: lessons from ipilimumab -- Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned -- Adjuvant strategies for vaccines: the use of adjuvants within the cancer vaccine setting -- Section 5: Improving immunotherapeutic responses. Epigenetic approaches: emerging role of histone deacetylase inhibitors in cancer immunotherapy -- Molecular profiling of immunotherapeutic resistance -- Immune stimulatory features of classical chemotherapy -- Immunotherapy and cancer therapeutics: a rich partnership -- Section 6: Targeting strategies to defeat immune suppression. JAK/STAT signaling in myeloid cells: targets for cancer immunotherapy -- Tumor-associated macrophages in cancer growth and progression -- Tumor-induced myeloid-derived suppressor cells -- HyperAcute vaccines: a novel cancer immunotherapy -- Tumor exosomes and their impact on immunity and cancer progression -- Galectins: key players in the tumor microenvironment -- IDO in immune escape: regulation and therapeutic inhibition -- IDO pathway: effect on Foxp3+ Tregs and cancer -- Arginase, nitric oxide synthase, and novel inhibitors of l-arginine metabolism in immune modulation
Control code
847527218
Edition
Second edition.
Extent
1 online resource (xxii, 655 pages)
Form of item
online
Isbn
9780123946331
Media category
computer
Media MARC source
rdamedia.
Media type code
  • c
Other physical details
illustrations (some color)
http://library.link/vocab/ext/overdrive/overdriveId
b4371df8-3eb4-441b-87f6-f641cd6a28c5
Specific material designation
remote
System control number
(OCoLC)847527218

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...